JP2019532041A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2019532041A5 JP2019532041A5 JP2019512835A JP2019512835A JP2019532041A5 JP 2019532041 A5 JP2019532041 A5 JP 2019532041A5 JP 2019512835 A JP2019512835 A JP 2019512835A JP 2019512835 A JP2019512835 A JP 2019512835A JP 2019532041 A5 JP2019532041 A5 JP 2019532041A5
- Authority
- JP
- Japan
- Prior art keywords
- alkyl
- formula
- compound
- substituted
- phenyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2023007868A JP2023055766A (ja) | 2016-09-01 | 2023-01-23 | アルケンホスホンアミデートまたはアルキンホスホンアミデートとの化学選択的チオールコンジュゲーション |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP16001917 | 2016-09-01 | ||
| EP16001917.0 | 2016-09-01 | ||
| PCT/EP2017/071937 WO2018041985A1 (en) | 2016-09-01 | 2017-09-01 | Chemoselective thiol-conjugation with alkene or alkyne-phosphonamidates |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023007868A Division JP2023055766A (ja) | 2016-09-01 | 2023-01-23 | アルケンホスホンアミデートまたはアルキンホスホンアミデートとの化学選択的チオールコンジュゲーション |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2019532041A JP2019532041A (ja) | 2019-11-07 |
| JP2019532041A5 true JP2019532041A5 (enExample) | 2020-10-01 |
| JP7217225B2 JP7217225B2 (ja) | 2023-02-02 |
Family
ID=56888890
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019512835A Active JP7217225B2 (ja) | 2016-09-01 | 2017-09-01 | アルケンホスホンアミデートまたはアルキンホスホンアミデートとの化学選択的チオールコンジュゲーション |
| JP2023007868A Pending JP2023055766A (ja) | 2016-09-01 | 2023-01-23 | アルケンホスホンアミデートまたはアルキンホスホンアミデートとの化学選択的チオールコンジュゲーション |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023007868A Pending JP2023055766A (ja) | 2016-09-01 | 2023-01-23 | アルケンホスホンアミデートまたはアルキンホスホンアミデートとの化学選択的チオールコンジュゲーション |
Country Status (6)
| Country | Link |
|---|---|
| US (4) | US11161873B2 (enExample) |
| EP (1) | EP3506949A1 (enExample) |
| JP (2) | JP7217225B2 (enExample) |
| CN (2) | CN117903297A (enExample) |
| AU (1) | AU2017320913B2 (enExample) |
| WO (1) | WO2018041985A1 (enExample) |
Families Citing this family (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US12453779B2 (en) | 2018-03-07 | 2025-10-28 | Forschungsverbund Berlin E.V. | Chemoselective thiol-conjugation with alkene or alkyne-phosphonothiolates and -phosphonates |
| CN109666044B (zh) * | 2018-07-04 | 2021-03-05 | 浙江大学 | 基于[2.2]对环芳烷骨架的有机磷化合物及其中间体和制备方法与用途 |
| JP2023503926A (ja) * | 2019-11-22 | 2023-02-01 | ザ・リージエンツ・オブ・ザ・ユニバーシテイー・オブ・カリフオルニア | Ｔａｓｐａｓｅ１阻害剤およびその使用 |
| US20230250461A1 (en) * | 2020-06-26 | 2023-08-10 | Yale University | Compositions and Methods for Selective Detection and/or Inhibition of Bacterial Pathogens in Microbial Communities |
| US20250269046A1 (en) | 2021-02-26 | 2025-08-28 | Forschungsverbund Berlin E.V. | Cellular uptake of large biomolecules enabled by cell-surface-reactive cell-penetrating peptide additives |
| US20240350655A1 (en) | 2021-04-23 | 2024-10-24 | Forschungsverbund Berlin E.V. | Thiol-conjugation with unsaturated phosphorus(v) compounds |
| US20230330258A1 (en) | 2021-11-09 | 2023-10-19 | Tubulis Gmbh | Conjugates comprising a phosphorus (v) and a drug moiety |
| PE20242114A1 (es) | 2021-11-09 | 2024-10-28 | Tubulis Gmbh | Conjugados que comprenden fosforo (v) y una fraccion molecular de camptotecina |
| WO2023105087A1 (en) | 2021-12-10 | 2023-06-15 | Tubulis Gmbh | Novel flt3 antibodies and antibody-drug-conjugates based thereon, therapeutic methods and uses thereof in combination with tyrosine kinase inhibitors |
| WO2024003002A1 (en) | 2022-06-27 | 2024-01-04 | Diaccurate | N-substituted indole derivatives and conjugates for the treatment of cancer |
| CN120112312A (zh) | 2022-10-18 | 2025-06-06 | Tubulis 股份有限公司 | 新型抗-tpbg抗体和基于其的抗体-药物偶联物、其治疗方法及用途 |
| KR20250089528A (ko) | 2022-10-18 | 2025-06-18 | 투불리스 게엠베하 | 신규한 napi2b 항체를 함유하는 신규한 항체 약물 접합체, 치료 방법 및 이의 용도 |
| IL320284A (en) | 2022-10-18 | 2025-06-01 | Tubulis Gmbh | Novel anti-napi2b antibodies and antibody-drug-conjugates based thereon, therapeutic methods and uses thereof |
| IL321506A (en) | 2022-12-22 | 2025-08-01 | Tubulis Gmbh | Conjugates comprising a phosphorus(v) moiety and a drug |
| KR20260065883A (ko) | 2023-09-01 | 2026-05-11 | 투불리스 게엠베하 | 포스포나미데이트 화합물의 제조 방법 |
| WO2025146313A1 (en) | 2024-01-04 | 2025-07-10 | Deutsches Krebsforschungszentrum | Phosphinites as reductive disulfide rebridging agents |
| US12521446B2 (en) | 2024-02-27 | 2026-01-13 | Bristol-Myers Squibb Company | Anti-CEACAM5 antibody drug conjugates |
| WO2026096695A1 (en) | 2024-10-31 | 2026-05-07 | Bristol-Myers Squibb Company | Anti-fucosyl-gm1 antibody drug conjugates |
| WO2026107136A1 (en) | 2024-11-14 | 2026-05-21 | Bristol-Myers Squibb Company | Anti-ceacam5 antibody drug conjugates for the treatment of cancer |
| US20260144885A1 (en) | 2024-11-22 | 2026-05-28 | Bristol-Myers Squibb Company | Anti-lrrc15 antibodies and uses thereof |
| US20260144884A1 (en) | 2024-11-22 | 2026-05-28 | Bristol-Myers Squibb Company | Anti-lrrc15 antibody drug conjugates |
| CN119391070A (zh) * | 2024-11-28 | 2025-02-07 | 宁波卡倍亿新材料科技有限公司 | 一种新能源汽车耐高温阻燃电缆料及其制备方法 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2535174A (en) | 1949-04-07 | 1950-12-26 | Us Rubber Co | Mercaptoethanephosphonates |
| DE2024250A1 (de) * | 1970-05-19 | 1971-12-02 | Farbwerke Hoechst AG, vorm. Meister Lucius & Brüning, 6000 Frankfurt | Antimikrobielle grenzflächenaktive Mittel |
| EP0859841B1 (en) | 1995-08-18 | 2002-06-19 | MorphoSys AG | Protein/(poly)peptide libraries |
| WO2010056847A2 (en) * | 2008-11-13 | 2010-05-20 | Taigen Biotechnology Co., Ltd. | Lyophilization formulation |
| CN102058547A (zh) * | 2009-11-12 | 2011-05-18 | 太景生物科技股份有限公司 | 冻干制剂 |
| EP2916872B1 (en) * | 2012-11-09 | 2019-02-27 | Innate Pharma | Recognition tags for tgase-mediated conjugation |
| JP2016538877A (ja) * | 2013-10-14 | 2016-12-15 | シンアフィックス ビー．ブイ． | 修飾糖タンパク質、タンパク質コンジュゲート及びそれらの調製方法 |
| CN106413758A (zh) | 2014-05-09 | 2017-02-15 | 拜耳医药股份有限公司 | 经由半胱氨酸氨基酸的成对c2桥联而使肽和蛋白质定向偶联的方法 |
-
2017
- 2017-09-01 WO PCT/EP2017/071937 patent/WO2018041985A1/en not_active Ceased
- 2017-09-01 EP EP17772314.5A patent/EP3506949A1/en active Pending
- 2017-09-01 CN CN202311230447.3A patent/CN117903297A/zh active Pending
- 2017-09-01 JP JP2019512835A patent/JP7217225B2/ja active Active
- 2017-09-01 US US16/328,199 patent/US11161873B2/en active Active
- 2017-09-01 AU AU2017320913A patent/AU2017320913B2/en active Active
- 2017-09-01 CN CN201780053946.6A patent/CN109689112B/zh active Active
-
2021
- 2021-08-30 US US17/460,791 patent/US11746124B2/en active Active
-
2023
- 2023-01-23 JP JP2023007868A patent/JP2023055766A/ja active Pending
- 2023-07-10 US US18/349,727 patent/US12171837B2/en active Active
-
2024
- 2024-11-26 US US18/960,256 patent/US20250090672A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2021531826A5 (enExample) | ||
| ES2565481T3 (es) | Anticuerpo anti-PlGF novedoso | |
| KR102056932B1 (ko) | 메디토프와 메디토프-결합 항체 및 이들의 용도 | |
| JP2021524270A5 (enExample) | ||
| KR102811956B1 (ko) | 암을 치료하기 위한 1-(피페리디노카보닐메틸)-2-옥소피페라진 유도체 | |
| KR102455340B1 (ko) | 최적화된 핵산 항체 작제물 | |
| JP2006507265A5 (enExample) | ||
| CN109715662A (zh) | 使用抑胃肽受体(gipr)结合蛋白与glp-1激动剂的组合来治疗或改善代谢病症的方法 | |
| CN110678208B (zh) | 膜融合脂质纳米颗粒和制造方法以及用于产生治疗性蛋白质和用于治疗的用途 | |
| PT1266025E (pt) | Esqueletos proteicos para imitadores de anticorpos e outras proteínas de ligação | |
| WO2015057671A1 (en) | Artificial transcription factors comprising a sliding domain and uses thereof | |
| CN106574301A (zh) | 通过引物延伸进行载玻片上染色 | |
| JPH02288898A (ja) | ヒトｂ細胞刺激因子２レセプター蛋白質 | |
| WO2014206304A1 (zh) | 高稳定性的t细胞受体及其制法和应用 | |
| JP2021524275A5 (enExample) | ||
| KR20230066491A (ko) | 다가 메디토프, 메디토프 결합 항체 및 이의 용도 | |
| RU2013128361A (ru) | Her2-связывающие белки, меченые комплексом 18f-фторида алюминия и nota | |
| CN113710688A (zh) | 用于治疗血液癌症和实体瘤癌症的嵌合抗原受体修饰的t细胞(car-t) | |
| JP2015504893A5 (enExample) | ||
| JP2010527922A5 (enExample) | ||
| JP2015517577A5 (enExample) | ||
| CN114438088A (zh) | 一种溶酶体靶向的核酸嵌合体的制备及应用 | |
| JP2024522183A (ja) | 非標準ｇ四重鎖構造に結合する化合物ならびにそれを作製および使用する方法 | |
| JP2023169422A (ja) | 結合ポリペプチドおよびそれを作製する方法 | |
| Aoki et al. | Mirror-image single-domain antibody for a novel nonimmunogenic drug scaffold |